Diabetes patients should have more voice in treatment: experts

October 2, 2012
Diabetes patients should have more voice in treatment: experts
New guidelines say individual, doctor and evidence must all contribute to decisions.

(HealthDay)—New guidelines meant to provide type 2 diabetes patients with truly individualized care have been issued by the American Diabetes Association and the European Association for the Study of Diabetes.

The new position statement recommends more patient involvement in the treatment and management of their condition and gives guidance on the rational approach to the choice of therapy. Choices—including precise goals for —should combine the best available scientific evidence with the doctor's and patient's own preferences.

"Given the uncertainties in terms of type and sequence of therapies, this approach is particularly appropriate in type 2 diabetes," Andrew Boulton, a professor at the University of Manchester, in England, and EASD president, said in a news release from the organization.

Among the other main points in the new guidelines:

  • Diet, exercise and education remain the foundation of any type 2 diabetes treatment program.
  • Unless there are good reasons for not using it, metformin (brand names include Fortamet, Glucophage, Glumetza and Riomet) is the best first-line drug.
  • After metformin, there is limited data to guide treatment. Combination therapy with an additional one or two oral or injectable drugs is reasonable, aiming to minimize side effects where possible.
  • Eventually, many patients will require alone or in combination with other drugs to maintain .
  • Comprehensive cardiovascular risk reduction must be a major focus of therapy.
The guidelines were scheduled for release Tuesday at the annual meeting of the EASD, in Berlin, and appear in the journal Diabetologia.

In the guidelines, patient-centered care is defined as "an approach to providing care that is respective and responsive to individual patient preferences, needs and values, ensuring that the patients' own values guide all clinical decisions."

Ultimately, patients make the final decision about their and, to some degree, the drug treatments they receive. Their diabetes care and management has to fit in with their lives.

Explore further: Patient-centered approach key for T2DM management

More information: The American Diabetes Association has more about diabetes treatment and care.

Related Stories

Patient-centered approach key for T2DM management

April 23, 2012
(HealthDay) -- Treatment of type 2 diabetes should be personalized in a patient-centered approach, with diet, exercise, and education forming the basis of any treatment program, supplemented by medications as necessary, according ...

Diabetes groups issue new guidelines on blood sugar

April 19, 2012
(HealthDay) -- Type 2 diabetes is a complex metabolic disorder, and treating the disease often requires a personalized, multi-pronged approach, say new expert guidelines on treating high blood sugar levels, issued Thursday.

ACP recommends metformin to treat type 2 diabetes based on CE analysis of oral medications

February 6, 2012
The American College of Physicians (ACP) recommends that clinicians add metformin as the initial drug treatment for most patients with type 2 diabetes when lifestyle modifications such as diet, exercise, and weight loss have ...

Patients with Type 2 diabetes may not benefit from oral medication as well as insulin

April 20, 2012
Patients suffering from type 2 diabetes may not benefit from taking both an oral glucose lowering drug (metformin) and insulin instead of insulin alone, a study published on bmj.com claims.

Study shows treating diabetes early, intensively is best strategy

June 28, 2012
Intensive early treatment of type 2 diabetes slows down progression of the disease by preserving the body's insulin-producing capacity, a UT Southwestern study has shown.

Recommended for you

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...

Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017
High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.